Novartis Given Reprieve In Elidel FCA Suit

Law360, New York (October 26, 2012, 7:46 PM EDT) -- A Pennsylvania federal judge on Friday dismissed a former Novartis Pharmaceuticals Corp. employee’s False Claims Act suit accusing the company of off-label marketing and kickbacks related to eczema treatment Elidel, but gave the former employee leave to amend his complaint.

Granting Novartis’ motion to dismiss, U.S District Judge Gene E.K. Pratter said relator Donald R. Galmines, a former Novartis senior sales consultant, had failed to sufficiently prove he had voluntarily provided information on his allegations to the federal government before filing his qui tam suit as...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.